Global Standardized Financials

44.02 -0.10(-0.22%)05/17/2024
Bristol-Myers Squibb Co. (BMY)
Income Statement
(Values in USD Thousands)
 2024-03-31 2023-09-30 2023-06-30 2023-03-31
Net Income-11,911,0001,928,0002,073,0002,262,000
Revenue11,865,00010,966,00011,226,00011,337,000
Cost Of Revenue2,932,0002,506,0002,876,0002,566,000
gross Profit8,933,0008,460,0008,350,0008,771,000
Operating Expenses7,419,0004,245,0006,449,0006,339,000
Selling General and Administrative Expenses2,367,0002,003,0001,934,0001,762,000
Research and Development Expenses2,695,0002,242,0002,258,0002,321,000
Other Expenses401,000565,000526,0002,256,000
Cost And Expenses10,351,0006,751,0009,325,0008,905,000
Operating Income3,871,0004,215,0004,158,0002,840,000
Income Tax Expense392,000203,000-218,000503,000
Income Before Tax-11,516,0002,137,0001,859,0002,770,000
Earning Per Share Basic-5.890.940.991.08
Earning Per Share Diluted-5.890.930.991.07
weighted Average Shares Outstanding2,023,0002,057,0002,093,0002,099,000
weighted Average Shares Outstanding (Diluted)2,023,0002,064,0002,102,0002,113,000
Gross Margin0.750.770.740.77
EBIT Margin0.370.380.410.45
Profit Margin-1.000.180.180.20
EBITDA4,447,0004,215,0004,626,0005,096,000
Earning Before Tax Margin-0.970.190.170.24